I-Study™ Think Tank
Towards a System Plan for Transformation of Cancer Care to a Molecular-Based Approach

 Thursday, May 30, 2013

Courtyard Marriott Chicago Downtown Magnificent Mile
165 E Ontario, Chicago IL 60611

AGENDA
Plenary

7:30 AM – Breakfast and Registration

8:00 AM – Welcome and Introduction: Dawn Van Dam, GM, CHA

8:10 AM – Keynote: Rick Wilson, Wash. Univ. School of Medicine

9:00 AM – Topic Introductions: Workshop Speakers

 Workshops

10:00 AM – Instructions for Workshops: Dawn Van Dam

10:15 AM – Moderated Workshops (Session I)

12:00 PM – Lunch and Networking (Plenary)

12:45 PM – Moderated Workshops (Session II)

2:30 PM – Prepare Findings: Workshop Moderators/Speakers

 Plenary

2:30 PM – Refreshments

3:00 PM – Workshop Presentations: Workshop Moderators/Speakers

4:30 PM – Close and Reception

Workshop Topics/Speakers/Moderators

A. The Risk Assessment/Prevention Phase: The New Assignments and Learning
Judy Garber, Director, Cancer Risk/Prevention Clinic, Dana Farber
Paula Rieger, CEO, Oncology Nurses Society

B. The Detection Phase: The New Learning and Assignments
Shashikant Kulkarni, Head of Clinical Genomics, Wash. Univ. School of Medicine
Nazneen Aziz, Director of Molecular Medicine, CAP

C. The Post-Treatment/Prognosis Phase: The New Learning and Assignments
Shyamali Singhal, Medical Director of the Cancer Center, El Camino Hospital
Mary Zutter, Director, Tumor-Host Interaction Pgm., Vanderbilt Ingram Cancer Ctr.

D. Which Genomic Challenges are Most Pressing
Nickolas Papadopoulos, Director of Translational Genetics, Johns Hopkins
Tim McDaniel, Director of Scientific Research, Illumina

E. Innovative Ideas/Approaches to Accelerate the Advance
Les Paul, CMO, Caris Life Science

F. Which Organizations Carry this Forward and How
John Sweetenham, CMO, Huntsman Cancer Institute
Peter Pitts, President, Center for Medicine in the Public Interest

REGISTER TO ATTEND